Clinical Trial Update: Brow Lifting With Dysport [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Dysport (abobotulinumtoxinA) for brow lifting in brow ptosis and lid ptosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoptosis
• Ptosis

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Kenneth Beer | Conditions: Brow Ptosis, Lid Ptosis | Phase 4 | Status: COMPLETED